Pinned post
Today we’re announcing our collaboration with @Roche to use Chai’s AI models for drug discovery.
More ↓
More ↓
0:09
Chai Discovery
Verified account This account is verified because it's an official organization on X. Learn more@chaidiscovery
5 Following 7.2K Followers 103 Posts
Latest posts 5
Chai Discovery has been named an AI Pioneer in the 2026 #Disruptors60, unveiled at @TechCrunch Disrupt.
Each year, 60 emerging AI startups are recognized as Disruptors, alongside 15 Pioneers already leading at scale.
We're in great company alongside @AppliedInt, @FireworksAI_HQ, @OpenEvidence and more. Full list ↓
Each year, 60 emerging AI startups are recognized as Disruptors, alongside 15 Pioneers already leading at scale.
We're in great company alongside @AppliedInt, @FireworksAI_HQ, @OpenEvidence and more. Full list ↓
Today, we’re announcing a collaboration with @GSK following its successful evaluation of Chai’s models.
@GSK tested designs from Chai's models in its own wet labs, generated zero-shot with no target-specific training, and found binders to all tested targets.
More ↓
@GSK tested designs from Chai's models in its own wet labs, generated zero-shot with no target-specific training, and found binders to all tested targets.
More ↓
0:07
AI in drug discovery isn't just a speed play. It unlocks new therapeutic strategies once out of reach.
At the CDD & AI for Biologics Summit today, Chai’s Ryan Peckner will share how Chai’s latest models can design precise, novel antibodies for hard targets:
cdd-ai-biologics.com/speaker/ryan-p…
At the CDD & AI for Biologics Summit today, Chai’s Ryan Peckner will share how Chai’s latest models can design precise, novel antibodies for hard targets:
cdd-ai-biologics.com/speaker/ryan-p…
Announcing Chai × @BMSnews.
BMS has spent decades developing medicines for patients with serious diseases.
Now it will leverage Chai's AI models to support future discoveries, unlocking challenging targets and compressing the timeline from drug concept to candidate.
BMS has spent decades developing medicines for patients with serious diseases.
Now it will leverage Chai's AI models to support future discoveries, unlocking challenging targets and compressing the timeline from drug concept to candidate.
0:13